The Russian Sputnik V coronavirus vaccine can be used in EU countries if all documents related to the drug are made public. This, according to the newspaper “Reedus”, said the head of the European Commission, Ursula von der Leyen.
The head of the European Commission stressed that EU experts must be confident in the safety of the vaccine.
The Lancet published the results of the test of “Sputnik V”
“If Russian manufacturers open access to their reports, demonstrate full transparency and release all data, then they will receive permission to enter the European market, along with other vaccine manufacturers,” said Ursula von der Leyen.
As Rambler reported, Sputnik V is the world's first vaccine against COVID-19. It was developed by the Gamaleya Research Center for Epidemiology and Microbiology and the 27th Central Research Institute of the Russian Ministry of Defense.
The interim results of the third phase of clinical trials of the Russian vaccine were published in the leading medical journal The Lancet. In a study based on an analysis of data from nearly 20,000 trial participants, three quarters of whom received the vaccine and one quarter received a placebo, it was noted that the effectiveness of vaccination against COVID-19 was 91.6%.
Europe agreed to use Sputnik V on a transparent basis
The writer appreciated the likelihood of Yeltsin getting into the Dyatlov group
In Roscosmos, the accident with the ship Elon Musk was explained by a malfunction in the engine
